951 related articles for article (PubMed ID: 22854419)
1. Adipokines, insulin resistance and hyperandrogenemia in obese patients with polycystic ovary syndrome: cross-sectional correlations and the effects of weight loss.
Spanos N; Tziomalos K; Macut D; Koiou E; Kandaraki EA; Delkos D; Tsourdi E; Panidis D
Obes Facts; 2012; 5(4):495-504. PubMed ID: 22854419
[TBL] [Abstract][Full Text] [Related]
2. Adipose expression of adipocytokines in women with polycystic ovary syndrome.
Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S
Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892
[TBL] [Abstract][Full Text] [Related]
3. Plasma visfatin level in women with polycystic ovary syndrome.
Dıkmen E; Tarkun I; Cantürk Z; Cetınarslan B
Gynecol Endocrinol; 2011 Jul; 27(7):475-9. PubMed ID: 20586547
[TBL] [Abstract][Full Text] [Related]
4. Impact of treatment with metformin on adipokines in patients with polycystic ovary syndrome.
Tarkun I; Dikmen E; Cetinarslan B; Cantürk Z
Eur Cytokine Netw; 2010 Dec; 21(4):272-7. PubMed ID: 21126943
[TBL] [Abstract][Full Text] [Related]
5. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
Diamanti-Kandarakis E; Katsikis I; Piperi C; Alexandraki K; Panidis D
Clin Endocrinol (Oxf); 2007 Jan; 66(1):103-9. PubMed ID: 17201808
[TBL] [Abstract][Full Text] [Related]
6. Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Kowalska I; Straczkowski M; Nikolajuk A; Adamska A; Karczewska-Kupczewska M; Otziomek E; Wolczynski S; Gorska M
Hum Reprod; 2007 Jul; 22(7):1824-9. PubMed ID: 17582143
[TBL] [Abstract][Full Text] [Related]
7. Are plasma levels of visfatin and retinol-binding protein 4 (RBP4) associated with body mass, metabolic and hormonal disturbances in women with polycystic ovary syndrome?
Olszanecka-Glinianowicz M; Madej P; Zdun D; Bożentowicz-Wikarek M; Sikora J; Chudek J; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2012 May; 162(1):55-61. PubMed ID: 22397743
[TBL] [Abstract][Full Text] [Related]
8. Serum adiponectin and resistin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome.
Olszanecka-Glinianowicz M; Kuglin D; Dąbkowska-Huć A; Skałba P
Eur J Obstet Gynecol Reprod Biol; 2011 Jan; 154(1):51-6. PubMed ID: 20889251
[TBL] [Abstract][Full Text] [Related]
9. Effects of weight loss induced by bariatric surgery on hepatic adipocytokine expression.
Moschen AR; Molnar C; Wolf AM; Weiss H; Graziadei I; Kaser S; Ebenbichler CF; Stadlmann S; Moser PL; Tilg H
J Hepatol; 2009 Oct; 51(4):765-77. PubMed ID: 19664840
[TBL] [Abstract][Full Text] [Related]
10. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
Panidis D; Farmakiotis D; Rousso D; Kourtis A; Katsikis I; Krassas G
Fertil Steril; 2008 Apr; 89(4):899-906. PubMed ID: 17980364
[TBL] [Abstract][Full Text] [Related]
11. Serum resistin and adiponectin levels in young non-obese women with polycystic ovary syndrome.
Arikan S; Bahceci M; Tuzcu A; Kale E; Gökalp D
Gynecol Endocrinol; 2010 Mar; 26(3):161-6. PubMed ID: 20148738
[TBL] [Abstract][Full Text] [Related]
12. Diet, physical exercise and Orlistat administration increase serum anti-Müllerian hormone (AMH) levels in women with polycystic ovary syndrome (PCOS).
Vosnakis C; Georgopoulos NA; Rousso D; Mavromatidis G; Katsikis I; Roupas ND; Mamali I; Panidis D
Gynecol Endocrinol; 2013 Mar; 29(3):242-5. PubMed ID: 23194076
[TBL] [Abstract][Full Text] [Related]
13. Adiponectin and resistin in PCOS: a clinical, biochemical and molecular genetic study.
Escobar-Morreale HF; Villuendas G; Botella-Carretero JI; Alvarez-Blasco F; Sanchón R; Luque-Ramírez M; San Millán JL
Hum Reprod; 2006 Sep; 21(9):2257-65. PubMed ID: 16675483
[TBL] [Abstract][Full Text] [Related]
14. Plasma visfatin levels in normal weight women with polycystic ovary syndrome.
Panidis D; Farmakiotis D; Rousso D; Katsikis I; Delkos D; Piouka A; Gerou S; Diamanti-Kandarakis E
Eur J Intern Med; 2008 Oct; 19(6):406-12. PubMed ID: 18848173
[TBL] [Abstract][Full Text] [Related]
15. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
Carmina E; Orio F; Palomba S; Longo RA; Cascella T; Colao A; Lombardi G; Rini GB; Lobo RA
Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
[TBL] [Abstract][Full Text] [Related]
16. [Clinical significance and changes of serum visfatin, adiponectin and leptin levels in patients with polycystic ovarian syndrome].
Wang Y; Yu P
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Jan; 34(1):72-5. PubMed ID: 19197132
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of insulin resistance and plasma levels for visfatin and resistin in obese and non-obese patients with polycystic ovary syndrome.
Gul OO; Cander S; Gul B; Açıkgoz E; Sarandol E; Ersoy C
Eur Cytokine Netw; 2015; 26(4):73-8. PubMed ID: 26967765
[TBL] [Abstract][Full Text] [Related]
18. Serum visfatin levels in women with polycystic ovary syndrome.
Güdücü N; İşçi H; Görmüş U; Yiğiter AB; Dünder I
Gynecol Endocrinol; 2012 Aug; 28(8):619-23. PubMed ID: 22313145
[TBL] [Abstract][Full Text] [Related]
19. The role of orlistat combined with lifestyle changes in the management of overweight and obese patients with polycystic ovary syndrome.
Panidis D; Tziomalos K; Papadakis E; Chatzis P; Kandaraki EA; Tsourdi EA; Katsikis I
Clin Endocrinol (Oxf); 2014 Mar; 80(3):432-8. PubMed ID: 23909452
[TBL] [Abstract][Full Text] [Related]
20. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
Pehlivanov B; Mitkov M
Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]